ContraFect Announces Pricing of 10.0 Million Registered Direct Offering and Concurrent Private Placement
Slightly above 67% of ContraFect Corp's investor base is looking to short. The analysis of current outlook of investing in ContraFect Corp suggests that many traders are alarmed regarding ContraFect Corp's prospects. ContraFect Corp's investing sentiment can be driven by a variety of factors including economic data, ContraFect Corp's earnings reports, geopolitical events, and overall market trends.
ContraFect |
YONKERS, N.Y., Feb. 28, 2023 -- ContraFect Corporation , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents , including lysins and
Read at benzinga.com
 |
ContraFect Corp Fundamental Analysis
We analyze ContraFect Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ContraFect Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ContraFect Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
ContraFect Corp is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
ContraFect Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ContraFect Corp stock to make a market-neutral strategy. Peer analysis of ContraFect Corp could also be used in its relative valuation, which is a method of valuing ContraFect Corp by comparing valuation metrics with similar companies.
Peers
ContraFect Corp Related Equities
| CNSP | Cns Pharmaceuticals | 27.27 | ||||
| UNCY | Unicycive Therapeutics | 5.36 | ||||
| DRMA | Dermata Therapeutics | 5.31 | ||||
| REVB | Revelation Biosciences | 2.88 | ||||
| VRAX | Virax Biolabs | 1.06 | ||||
| PALI | Palisade Bio | 0.97 | ||||
| ALLR | Allarity Therapeutics | 2.97 | ||||
| QNRX | Quoin Pharmaceuticals | 6.06 | ||||
| WINT | Windtree Therapeutics | 6.67 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in ContraFect Stock
If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |